Literature DB >> 18374944

Nitric oxide donor improves healing if applied on inflammatory and proliferative phase.

Thaís P Amadeu1, Amedea B Seabra, Marcelo G de Oliveira, Andréa Monte-Alto-Costa.   

Abstract

BACKGROUND: Nitric oxide (NO) is an important molecule synthesized during wound repair. Studies have reported the use of NO donors on cutaneous wound repair, but their effects in different phases of healing are still not elucidated. The aim of this work was to investigate the effects of topical application of a NO donor (S-nitrosoglutathione, GSNO)-containing hydrogel on excisional wounds in the inflammatory ((inf)), proliferative ((prol)), and inflammatory and proliferative phases ((inf+prol)) of rat cutaneous wound repair.
MATERIAL AND METHODS: In each group (control, GSNO(inf), GSNO(prol), and GSNO(inf+prol)), excisional wounds on the dorsal surface were made and wound contraction and re-epithelialization were evaluated. Fourteen days after wounding, wounds and adjacent skin were formalin-fixed and paraffin-embedded. Collagen fibers organization, mast cells, myofibroblasts and vessels were evaluated.
RESULTS: Wound contraction of the GSNO(inf+prol) group was faster than control, GSNO(inf), and GSNO(prol) groups, 5 and 7 d after wounding. Topical application of GSNO accelerated re-epithelialization 14 d after wounding, mainly in GSNO(inf+prol) group. In addition, the GSNO(inf+prol) group showed improved collagen fibers maturation and tissue organization, and lower amount of inflammatory cells in the superficial and deep areas of the granulation tissue, compared with the other groups.
CONCLUSIONS: NO is important in all phases of rat cutaneous wound repair, but if applied on inflammatory and proliferative phases, the improvement in wound healing (accelerating wound closure, wound re-epithelialization, and granulation tissue organization) is more impressive.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18374944     DOI: 10.1016/j.jss.2007.10.015

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  23 in total

Review 1.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

2.  The role of nitric oxide during healing of trauma to the skeletal muscle.

Authors:  Lidiane Isabel Filippin; María José Cuevas; Elena Lima; Norma Possa Marroni; Javier Gonzalez-Gallego; Ricardo Machado Xavier
Journal:  Inflamm Res       Date:  2010-11-13       Impact factor: 4.575

Review 3.  Nitric oxide release: part II. Therapeutic applications.

Authors:  Alexis W Carpenter; Mark H Schoenfisch
Journal:  Chem Soc Rev       Date:  2012-02-24       Impact factor: 54.564

4.  Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications.

Authors:  Michele C Jen; María C Serrano; Robert van Lith; Guillermo A Ameer
Journal:  Adv Funct Mater       Date:  2012-01-25       Impact factor: 18.808

5.  Deficiency of endothelial nitric oxide signaling pathway exacerbates peritoneal fibrosis in mice.

Authors:  Hiroyuki Kadoya; Minoru Satoh; Hajime Nagasu; Tamaki Sasaki; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2014-09-13       Impact factor: 2.801

6.  Winner of the society for biomaterials young investigator award for the annual meeting of the society for biomaterials, April 11-14, 2018, Atlanta, GA: S-nitrosated poly(propylene sulfide) nanoparticles for enhanced nitric oxide delivery to lymphatic tissues.

Authors:  Alex Schudel; Lauren F Sestito; Susan N Thomas
Journal:  J Biomed Mater Res A       Date:  2018-03-05       Impact factor: 4.396

Review 7.  Biocompatible materials for continuous glucose monitoring devices.

Authors:  Scott P Nichols; Ahyeon Koh; Wesley L Storm; Jae Ho Shin; Mark H Schoenfisch
Journal:  Chem Rev       Date:  2013-02-07       Impact factor: 60.622

Review 8.  Nitric Oxide Therapy for Diabetic Wound Healing.

Authors:  Maggie J Malone-Povolny; Sara E Maloney; Mark H Schoenfisch
Journal:  Adv Healthc Mater       Date:  2019-01-15       Impact factor: 9.933

9.  Chaperonin containing T-complex polypeptide subunit eta (CCT-eta) is a specific regulator of fibroblast motility and contractility.

Authors:  Latha Satish; Sandra Johnson; James H-C Wang; J Christopher Post; Garth D Ehrlich; Sandeep Kathju
Journal:  PLoS One       Date:  2010-04-30       Impact factor: 3.240

10.  Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.

Authors:  Jeff S Isenberg; Sruti Shiva; Mark Gladwin
Journal:  Nitric Oxide       Date:  2009-05-27       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.